CD36 and atherosclerosis: Considering the profound effect of Nrf2-dependent transcriptional induction of CD36 in macrophages and the resulting impact on atherosclerosis, it is important to consider the potential pro-atherosclerotic effects of Nrf2 when designing Nrf2-targeted therapies.